Amylyx Pharmaceuticals, Inc. (AMLX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

1.9700

-0.0200

(-1.01%)

At close: 04:00PM EDT

2.0000

+0.03

(+1.52%)

After hours:

06:50PM EDT

Loading interactive chart...

Business Wire
Amylyx Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024
CAMBRIDGE, Mass., May 02, 2024--Amylyx Pharmaceuticals, Inc. (Nasdaq: AMLX) ("Amylyx" or the "Company") will report its first quarter 2024 financial results on Thursday, May 9, 2024. Amylyx’ senior management team will host a conference call and audio webcast at 8:00 a.m. ET to discuss the financial results and other company updates.
Zacks
The Zacks Analyst Blog Highlights Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals
Bristol Myers, Moderna, 2seventy bio, Amylyx Pharmaceuticals and Syros Pharmaceuticals are part of the Zacks top Analyst Blog.
Zacks
Biotech Stock Roundup: MRNA Up on Vaccine Data, BMY's Updates & More News
Moderna (MRNA) and Bristol Myers (BMY) are in focus on pipeline and regulatory updates.